… drug reviews and the postapproval addition of clinically significant adverse reactions to package inserts: a retrospective analysis of pre‐approval drug review reports …

K Watanabe, M Murakami, K Masuyama… - … and Drug Safety, 2018 - Wiley Online Library
… and risk minimization activities is heavily dependent on whether the safety specifications
have … In order to allow the monitoring period to all target drugs, we analyzed drugs containing …

Trends in FDA Transporter‐Based Post‐Marketing Requirements and Commitments Over the Last Decade

IR Younis, P Manchandani… - Clinical Pharmacology …, 2022 - Wiley Online Library
… and sponsors agree should be conducted post-approval with … or labeling suggest monitoring
and dose adjustment as … P-gp, 2 PMRs specified rosuvastatin as a probe substrate for …

[HTML][HTML] Evaluation of rosuvastatin-induced QT prolongation risk using real-world data, in vitro cardiomyocyte studies, and mortality assessment

Y Koo, SA Hyun, BJ Choi, Y Kim, TY Kim, HS Lim… - Scientific Reports, 2023 - nature.com
… also affected the sodium and calcium channel activities of … by the Food and Drug
Administration in 2003, is used to treat … , rosuvastatin should be used with active monitoring for QT …

Pharmacogenetic labeling of FDA-approved drugs: a regulatory retrospective

K Drozda, MA Pacanowski, C Grimstein… - JACC: Basic to …, 2018 - jacc.org
… in the pre- or post-approval setting, and revisions might be triggered by scientists at the FDA,
the … /cleared tests, merits of testing beyond INR monitoring, and actual feasibility of genetic …

Management of residual risk after statin therapy

C Reith, J Armitage - Atherosclerosis, 2016 - Elsevier
… Fibrates are a class of lipid modifying drugs which are … the extent to which they are used
post-approval will be their cost … by the independent data monitoring committee due to insufficient …

The proper role of the FDA for the 21st century

J Briggeman, E Roberts, J Gulfo - MERCATUS RESEARCH, 2016 - papers.ssrn.com
… that show activity on specific disease parameters and are safe may … symptoms and to
improve monitoring and communication of … restrictiveness is also manifest in required post-approval

Rosuvastatin: Beyond the cholesterol-lowering effect

F Cortese, M Gesualdo, A Cortese, S Carbonara… - Pharmacological …, 2016 - Elsevier
Food and drug administration approved its use for adults patients with primary … Like other
drugs of this class, the benefits of rosuvastatin are independent of LDL-C baseline levels but …

[PDF][PDF] The Proper Role of the FDA for the 21st Century

JV Gulfo, J Briggeman, EC Roberts - Mercatus Research, Mercatus …, 2016 - mercatus.org
… that show activity on specific disease parameters and are safe may … symptoms and to
improve monitoring and communication of … restrictiveness is also manifest in required post-approval

Effect of lawyer-submitted reports on signals of disproportional reporting in the food and drug administration's adverse event reporting system

JR Rogers, A Sarpatwari, RJ Desai, JM Bohn, NF Khan… - Drug Safety, 2019 - Springer
… role in the post-approval surveillance of prescription drugs and … or class action litigation—involving
rosuvastatin during the … this study was exempt from Institutional Review Board review. …

Medications safety resources and tools

AI Fathelrahman - Drug Safety in Developing Countries, 2020 - Elsevier
… which how the FDA evaluates drug safety information, how it … term postmarketing surveillance
to indicate PV activities, in … drug utilization review, is more like a research activity, although …